REMINDER: Our user survey closes on Friday, please submit your responses here.
Looks like a few were triggered. Someone is wanting some stock. No reason for the price fall.
@Swag I apologise for thinking you were a troll. Sounds like you're an investor here after all
Can you remind me what your target price is for odx?
@Robort agreed. The mologic test (which includes visitect) is being backed heavily under the Radx scheme. Can't but help our cause that Gates is now anchoring mologic
If you want to write a quick email to Craig to ask him to investigate why harmless posts are being taken down.
Seems this board has been hijacked by certain nasty characters
@Doc the MAP has been given in at least a couple of UK hospitals from speaking to a respi friend working in adult ICU. It's managed by Clinigen on a reactive basis. It's currently unlicensed so cannot be promoted by the company. You can call clinigen and ask them if the scheme is open and they will say. You just might not be able to request supply unless you're a relevant clinician and suitable patient.
Healthcare professionals in the EU can obtain details about the SNG001 Managed Access Program by calling the customer service team at +44 (0) 1283 494 340 or emailing medicineaccess@clinigengroup.com.
Patients seeking information should contact their physician.
@Mars £47k award. Wonder how much they are supplying and why. Wouldn't say this is screwing UK LFT
@Benny 100%. Which is why they won't answer that question or report you to LSE in the case of TWATCHER when you ask their target price.
@Gary in all seriousness that's your target?
@Gary what's your target price for ODX?
Don't engage with them. Filter the following:
Gary
Shelly
Twatcher
Swag